JPRN-UMIN000007215已完成4 期
A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancer - A cohort study on Bevacizumab in patients with advanced non-small-cell lung cancer excluding squamous cell lung cancer
agasaki thoracic oncology group0 个研究点目标入组 120 人开始时间: 2012年2月2日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
4 期
A cohort study on Bevacizumab in patients with advansed non-small-cell lung cancer excluding squamous cell lung cancerJPRN-UMIN000006717Ibaraki respiratory tract tumor study group200
招募中
不适用
A clinical study of Bevacizumab therapy in combination with chemotherapeutic drugs for children with recurrent gliomaJPRN-UMIN000005528Osaka University Graduate School of Medicine12
进行中（未招募）
不适用
Bevacizumab+folfiri in untreated patients with advanced colorectal cancer. A phase II multicenter study of the Gruppo Oncologico dell'Italia Meridionale. (GOIM). - Bevacizumab+folfiri in untreated patients with advanced colorectal canceuntreated patients with advanced colorectal cancer.MedDRA version: 9.1Level: LLTClassification code 10010035Term: Colorectal cancer stage IVEUCTR2006-002887-25-ITGOIM GRUPPO ONCOLOGICO MERIDIONALE
招募中
3 期
Clinical Trial of bevacizumab in patients with retinopathy of prematurityretinopathy of prematurityJPRN-jRCT2091220073obuhisa Naoi,MDDepartment of Ophthalmology,School of MedicineUniversity of Miyazaki40
招募中
不适用
Phase II study of Bevacizumab in combination with Paclitaxel in metastatic breast cancer patients with asymptomatic brain metastases.Breast CancerJPRN-UMIN000010466Kansai medical university23